Pasar al contenido principal

INTERACCIONES GENICAS Y PROTEICAS DE CD69 Y SUS REGIONES GENICAS REGULADORAS CON MOLECULAS IMPLICADAS EN LA ACTIVACION INMUNOLOGICA.

PID2021-125757OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Closer Peptide Repertoire Similarity of HLA-B∗14, 03 and HLA-B∗27:05 Sheds Light on Ankylosing Spondylitis Susceptibility, Molecular & Cellular Proteomics

  • Cobos-Figueroa, Laura
  • Robles-Parrado, Javier
  • Alari Pahissa, Elisenda|||0000-0001-7424-5383
  • Galocha, Begoña
  • Mir, Carmen
  • Pintor-Poveda, Ana
  • Barnea, Eilon
  • Admon, Arie|||0000-0003-0504-3950
  • Lauzurica, Pilar|||0000-0001-6579-1948
  • Lorente, Elena
The human major histocompatibility complex class I gene HLA-B∗27 is the main risk factor for ankylosing spondylitis (AS) through a mechanism that remains unknown. In African populations, where B∗27 is rare, the B∗14:03 allotype is strongly associated with AS, whereas B∗14:02, which differs at only one residue (L156R), is not associated. Using large-scale mass spectrometry-based peptide sequencing, we analyzed the peptidomes of HLA-B∗14:03, HLA-B∗14:02, and HLA-B∗27:05, obtaining more than 2000 ligands for each. Remarkably, we identified 1011 peptides shared by the AS-associated HLA-B∗27:05 and B∗14:03 alleles but not by the non-AS-associated B∗14:02 allele. Surprisingly, although B∗14:03 and B∗27:05 differ by 15 amino acids in their peptide-binding domain, they share a large portion of their ligands (64 and 43%, respectively), while B∗14:03 and B∗14:02, differing by only one residue, show less overlap (33-35%). The B∗14:03 peptide repertoire most closely resembles that of B∗27:05 at the P1, P2, and P5 peptide positions but diverges at the C-terminus, where B∗14:03 is more selective. Structural modeling suggests that the L156R difference between B∗14 alleles may induce long-range effects on peptide binding at P1, P2, and P5 residues, explaining the distinct repertoires. Most of the 1011 shared ligands contained R/K/A/G at P1, R at P2, and L/F at the C-terminus. Of these, ten peptides were previously identified as ligands of the three HLA-B∗27 subtypes most strongly associated with AS and are absent in nonassociated subtypes, while four peptides from the HLA 169 to 181 region-previously implicated in AS pathogenesis-were also identified, suggesting that differential peptide binding may influence disease development. In summary, the AS-associated allotypes B∗14:03 and B∗27:05, but not the non-AS-associated allotype B∗14:02, share similar peptide repertoires and binding characteristics, supporting specific common peptide ligands of HLA-B∗27:05 and B∗14:03 as a mechanism to explain the development of AS.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Closer peptide repertoire similarity of HLA-B*14:03 and HLA-B*27:05 sheds light on Ankylosing Spondylitis susceptibility

  • Cobos-Figueroa, Laura
  • Robles-Parrado, Javier
  • Alari-Pahissa, Elisenda
  • Galocha, Begoña
  • Mir, Carmen
  • Pintor-Poveda, Ana
  • Barnea, Elion
  • Admon, Arie
  • Lauzurica, Pilar
  • Lorente, Elena
The human major histocompatibility complex class I gene HLA-B∗27 is the main risk factor for ankylosing spondylitis (AS) through a mechanism that remains unknown. In African populations, where B∗27 is rare, the B∗14:03 allotype is strongly associated with AS, whereas B∗14:02, which differs at only one residue (L156R), is not associated. Using large-scale mass spectrometry-based peptide sequencing, we analyzed the peptidomes of HLA-B∗14:03, HLA-B∗14:02, and HLA-B∗27:05, obtaining more than 2000 ligands for each. Remarkably, we identified 1011 peptides shared by the AS-associated HLA-B∗27:05 and B∗14:03 alleles but not by the non-AS-associated B∗14:02 allele. Surprisingly, although B∗14:03 and B∗27:05 differ by 15 amino acids in their peptide-binding domain, they share a large portion of their ligands (64 and 43%, respectively), while B∗14:03 and B∗14:02, differing by only one residue, show less overlap (33-35%). The B∗14:03 peptide repertoire most closely resembles that of B∗27:05 at the P1, P2, and P5 peptide positions but diverges at the C-terminus, where B∗14:03 is more selective. Structural modeling suggests that the L156R difference between B∗14 alleles may induce long-range effects on peptide binding at P1, P2, and P5 residues, explaining the distinct repertoires. Most of the 1011 shared ligands contained R/K/A/G at P1, R at P2, and L/F at the C-terminus. Of these, ten peptides were previously identified as ligands of the three HLA-B∗27 subtypes most strongly associated with AS and are absent in nonassociated subtypes, while four peptides from the HLA 169 to 181 region-previously implicated in AS pathogenesis-were also identified, suggesting that differential peptide binding may influence disease development. In summary, the AS-associated allotypes B∗14:03 and B∗27:05, but not the non-AS-associated allotype B∗14:02, share similar peptide repertoires and binding characteristics, supporting specific common peptide ligands of HLA-B∗27:05 and B∗14:03 as a mechanism to explain the development of AS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Thyroid hormone deficiency worsens outcomes in vaccinia virus infection

  • Notario, Laura
  • Guerrero-Espinosa, Erika
  • Nistal, Manuel
  • Lauzurica, Pilar
  • Aranda, Ana
  • Alemany, Susana
Intranasal inhalation of the vaccinia virus in mice leads to acute lung infection followed by peripheral organ damage. Our findings demonstrate that hypothyroidism significantly exacerbates disease severity. Hypothyroid mice exhibit higher disease scores, elevated lung viral loads, and more extensive tissue damage in both the lungs and peripheral organs. Notably, only hypothyroid mice reach the experimental endpoint, underscoring their heightened vulnerability. Hypothyroid mice display a defective splenic immune response, with no amplification of T and B lymphocytes, but the increased susceptibility to vaccinia virus infection also persists in hypothyroid lymphocyte-deficient Rag2-/- mice. Prior to infection, hypothyroid mice show a reduced pool of lung alveolar macrophages, and lung viral loads are significantly elevated in these animals as early as 1 day post-infection, suggesting that an impaired innate immune response is involved in their increased susceptibility to vaccinia virus. Indeed, transfer of primary alveolar macrophages into the alveolar macrophage-deficient lungs of hypothyroid mice significantly alleviates disease symptoms. In euthyroid mice, circulating thyroid hormone levels decrease during infection, a well-documented response in sepsis and critical illness, known as non-thyroidal illness syndrome. Further highlighting the link between thyroid hormones and immune defense, we show that SRT1720, a Sirtuin 1 activator, reduces thyroid hormone levels and also worsens vaccinia infection when administered to euthyroid mice. In summary, our study reveals that hypothyroidism aggravates vaccinia virus infection. While the role of thyroid hormone decline in various diseases remains a topic of debate, our results suggest that thyroid hormones play a protective role in viral pulmonary infections., This work was funded by grants PID2020-116146RB-I00 from MCIN/AEI/ 10.13039/501100011033 and B2017/BMD-3724 to S.A. and A.A. from the Comunidad de Madrid, as well as PID2021-1257570B-100 from AEI and PI22CIII from AESI to P.L., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Mamíferos - Roedores, in vitro - Tipos celulares - líneas estables animales no humanas
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Closer peptide repertoire similarity of HLA-B*14:03 and HLA-B*27:05 sheds light on Ankylosing Spondylitis susceptibility

  • Cobos-Figueroa, Laura
  • Robles-Parrado, Javier
  • Alari-Pahissa, Elisenda
  • Galocha, Begoña
  • Mir, Carmen
  • Pintor-Poveda, Ana
  • Barnea, Elion
  • Admon, Arie
  • Lauzurica, Pilar
  • Lorente, Elena
The human major histocompatibility complex class I gene HLA-B∗27 is the main risk factor for ankylosing spondylitis (AS) through a mechanism that remains unknown. In African populations, where B∗27 is rare, the B∗14:03 allotype is strongly associated with AS, whereas B∗14:02, which differs at only one residue (L156R), is not associated. Using large-scale mass spectrometry-based peptide sequencing, we analyzed the peptidomes of HLA-B∗14:03, HLA-B∗14:02, and HLA-B∗27:05, obtaining more than 2000 ligands for each. Remarkably, we identified 1011 peptides shared by the AS-associated HLA-B∗27:05 and B∗14:03 alleles but not by the non-AS-associated B∗14:02 allele. Surprisingly, although B∗14:03 and B∗27:05 differ by 15 amino acids in their peptide-binding domain, they share a large portion of their ligands (64 and 43%, respectively), while B∗14:03 and B∗14:02, differing by only one residue, show less overlap (33-35%). The B∗14:03 peptide repertoire most closely resembles that of B∗27:05 at the P1, P2, and P5 peptide positions but diverges at the C-terminus, where B∗14:03 is more selective. Structural modeling suggests that the L156R difference between B∗14 alleles may induce long-range effects on peptide binding at P1, P2, and P5 residues, explaining the distinct repertoires. Most of the 1011 shared ligands contained R/K/A/G at P1, R at P2, and L/F at the C-terminus. Of these, ten peptides were previously identified as ligands of the three HLA-B∗27 subtypes most strongly associated with AS and are absent in nonassociated subtypes, while four peptides from the HLA 169 to 181 region-previously implicated in AS pathogenesis-were also identified, suggesting that differential peptide binding may influence disease development. In summary, the AS-associated allotypes B∗14:03 and B∗27:05, but not the non-AS-associated allotype B∗14:02, share similar peptide repertoires and binding characteristics, supporting specific common peptide ligands of HLA-B∗27:05 and B∗14:03 as a mechanism to explain the development of AS.